Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Overview of attention for article published in BMC Cancer, December 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,619 followers.

New from #The_MRC https://t.co/WjSeW1nTVr Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.